Conversely, genes such as ZMYND11, MAPK8, and RPS3 exhibit notable upregulation in surrounding non‐neoplastic tissues and function as prognostic safeguarding elements for GBM patients, possibly exerting antineoplastic effects by promoting programed cell death and curbing neoplastic cell multiplication. This evidence concerns the gene MAPK8 and glioblastoma.